Efficacy of rituximab as a single-agent therapy for the treatment of granulomatous and lymphocytic interstitial lung disease in patients with common variable immunodeficiency-Reference-Cited by-同舟云学术

Efficacy of rituximab as a single-agent therapy for the treatment of granulomatous and lymphocytic interstitial lung disease in patients with common variable immunodeficiency

Published:2019-03 Issue:3 Volume:7 Page:1055-1057.e2
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Cereser Lorenzo,De Carli Riccardo,Girometti Rossano,De Pellegrin Alessandro,Reccardini Federico,Frossi Barbara,De Carli Marco

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference10 articles.

1. British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the definition, diagnosis, and management of granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency disorders;Hurst;J Allergy Clin Immunol Pract,2017

2. Defective cellular immune response in vitro in common variable immunodeficiency;Cunningham-Rundles;J Clin Immunol,1981

3. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID);Chase;J Clin Immunol,2013

4. High resolution computed tomography and pulmonary function in common variable immunodeficiency;Gregersen;Respir Med,2009

5. Sirolimus as an alternative treatment in patients with granulomatous-lymphocytic lung disease and humoral immunodeficiency with impaired regulatory T cells;Deyà-Martínez;Pediatr Allergy Immunol,2018

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approach to diagnosing and managing granulomatous-lymphocytic interstitial lung disease;eClinicalMedicine;2024-09

2. Rituximab Monotherapy Is Effective as First-Line Treatment for Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in CVID Patients;Journal of Clinical Immunology;2023-09-27

3. Granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency;Rare Diseases of the Respiratory System;2023-06-01

4. Treatment of inflammatory complications in common variable immunodeficiency (CVID): current concepts and future perspectives;Expert Review of Clinical Immunology;2023-04-06

5. Rituximab as a single agent for successful treatment of granulomatous and lymphocytic interstitial lung disease in a pediatric patient with common variable immunodeficiency;The Journal of Allergy and Clinical Immunology: In Practice;2021-10